Hodgkin Lymphoma - Metabolic Tumor Volume as Prognostic Factor, Role of Radiotherapy, BV + AVD Study and Nivolumab Study | VuMedi

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

10 seconds

Playback speed

University of Miami Sylvester Comprehensive Cancer Center

Hodgkin Lymphoma - Metabolic Tumor Volume as Prognostic Factor, Role of Radiotherapy, BV + AVD Study and Nivolumab Study

By University of Miami Sylvester Comprehensive Cancer Center FEATURING Craig Moskowitz

By University of Miami Sylvester Comprehensive Cancer Center FEATURING Craig Moskowitz

269 views

November 19, 2018

Comments 0

Login to view comments. Click here to Login